memodio

About

Through groundbreaking technology, we are revolutionizing dementia care at memodio. As a pioneer in digital therapeutics, we have developed the first medical app specifically designed for the prevention and treatment of early-stage dementia and mild cognitive impairment (MCI). Our innovative solution bridges the critical gap between diagnosis and care, offering patients a scientifically validated, multimodal therapy plan directly on their smartphones. By leveraging advanced algorithms and the latest medical research, memodio creates personalized treatment programs that adapt to each user's unique cognitive and physical profile. Our platform integrates brain training, physical exercise, nutritional guidance, and risk factor management into a seamless, user-friendly experience. We are committed to empowering patients to maintain their independence and quality of life for as long as possible. Founded by a team of medical doctors and software engineers from the Hasso Plattner Institute and the University of Potsdam, memodio combines clinical expertise with cutting-edge digital engineering. We are not just building an app; we are defining a new standard of care for neurodegenerative diseases, ensuring that effective, evidence-based therapy is accessible to everyone, everywhere.